Sensor Optimization of Cardiac Resynchronization Therapy Response
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | July 2013 |
End Date: | April 2016 |
Contact: | SOCR Clinical Trial Leader |
Email: | medtronicCRMtrials@medtronic.com |
Sensor Optimization of CRT Response
The Sensor Optimization of Cardiac Resynchronization Therapy (CRT) Response (SOCR) Study is
a multicenter, prospective, non-randomized acute feasibility study that is being conducted
to determine if subcutaneous heart sounds and/or intracardiac impedance can acutely identify
the optimal atrioventricular (AV) pacing intervals and optimal left ventricular (LV)
electrodes in patients indicated for cardiac resynchronization therapy.
a multicenter, prospective, non-randomized acute feasibility study that is being conducted
to determine if subcutaneous heart sounds and/or intracardiac impedance can acutely identify
the optimal atrioventricular (AV) pacing intervals and optimal left ventricular (LV)
electrodes in patients indicated for cardiac resynchronization therapy.
Inclusion Criteria:
- Subject must be undergoing implant of a new or replacement/upgrade Medtronic CRT-P or
CRT-D device for approved indications.
- Subject is implanted or will be implanted with an right ventricular (RV) lead that
supports bipolar pacing and sensing (e.g. a bipolar pace/sense lead or a true bipolar
defibrillation leads)
- Subject (or subject's legally authorized representative) must be willing to give
informed consent
- Subjects must be at least 18 years of age
Exclusion Criteria:
- Subject has congenital heart disease
- Subject has a tachyarrhythmia (atrial and/or ventricular) at the time of enrollment
and a cardioversion will not be attempted prior to the research procedure
- Subject has unstable coronary artery disease
- Subject cannot undergo transvenous catheterization
- Subject has a mechanical tricuspid or aortic valve prosthesis or history of
significant structural tricuspid or aortic valvular disease
- Subject requires dual chamber cardiac pacing or single chamber (ventricular) pacing
at rest for rate control
- Subject has a recent echocardiogram (within prior 6 months) which revealed the
presence of an LV thrombus
- Subject is pregnant
- Subject is enrolled in a concurrent study that may confound the results of this study
without documented pre-approval from Medtronic study manager
We found this trial at
4
sites
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials